| Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10 ML Maeder, M Stefanidakis, CJ Wilson, R Baral, LA Barrera, ... Nature medicine 25 (2), 229-233, 2019 | 632 | 2019 |
| Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer MN Skor, EL Wonder, M Kocherginsky, A Goyal, BA Hall, Y Cai, ... Clinical Cancer Research 19 (22), 6163-6172, 2013 | 202 | 2013 |
| UDiTaS™, a genome editing detection method for indels and genome rearrangements G Giannoukos, DM Ciulla, E Marco, HS Abdulkerim, LA Barrera, ... BMC genomics 19, 1-10, 2018 | 124 | 2018 |
| Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma EM Stringer-Reasor, GM Baker, MN Skor, M Kocherginsky, E Lengyel, ... Gynecologic oncology 138 (3), 656-662, 2015 | 80 | 2015 |
| Discovery of a glucocorticoid receptor (GR) activity signature using selective GR antagonism in ER-negative breast cancer DC West, M Kocherginsky, EY Tonsing-Carter, DN Dolcen, DJ Hosfield, ... Clinical Cancer Research 24 (14), 3433-3446, 2018 | 71 | 2018 |
| Serum and glucocorticoid-regulated kinase 1 (SGK1) activation in breast cancer: requirement for mTORC1 activity associates with ER-alpha expression BA Hall, TY Kim, MN Skor, SD Conzen Breast cancer research and treatment 135, 469-479, 2012 | 57 | 2012 |
| Chronic social isolation is associated with metabolic gene expression changes specific to mammary adipose tissue PA Volden, EL Wonder, MN Skor, CM Carmean, FN Patel, H Ye, ... Cancer Prevention Research 6 (7), 634-645, 2013 | 51 | 2013 |
| Mammary adipose tissue-derived lysophospholipids promote estrogen receptor–negative mammary epithelial cell proliferation PA Volden, MN Skor, MB Johnson, P Singh, FN Patel, MK McClintock, ... Cancer Prevention Research 9 (5), 367-378, 2016 | 43 | 2016 |
| A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer R Nanda, EM Stringer-Reasor, P Saha, M Kocherginsky, J Gibson, ... Springerplus 5, 1-9, 2016 | 35 | 2016 |
| Hsp90 inhibition results in glucocorticoid receptor degradation in association with increased sensitivity to paclitaxel in triple-negative breast cancer AS Agyeman, WJ Jun, DA Proia, CR Kim, MN Skor, M Kocherginsky, ... Hormones and Cancer 7, 114-126, 2016 | 33 | 2016 |
| 124. Therapeutic correction of an LCA-causing splice defect in the CEP290 gene by CRISPR/Cas-mediated gene editing ML Maeder, R Mepani, S Gloskowski, M Skor, MK Collins, S Shen, ... Molecular Therapy 24, S51-S52, 2016 | 21* | 2016 |
| Glucocorticoid receptor C h IP‐sequencing of subcutaneous fat reveals modulation of inflammatory pathways P Singh, CO Brock, PA Volden, K Hernandez, M Skor, M Kocherginsky, ... Obesity 23 (11), 2286-2293, 2015 | 12 | 2015 |
| Metabolism of megestrol acetate in vitro and the role of oxidative metabolites L House, MJ Seminerio, S Mirkov, J Ramirez, M Skor, JR Sachleben, ... Xenobiotica 48 (10), 973-983, 2018 | 8 | 2018 |
| Gene expression of peripheral blood cells reveals pathways downstream of glucocorticoid receptor antagonism and nab-paclitaxel treatment JC Maranville, R Nanda, GF Fleming, MN Skor, A Di Rienzo, SD Conzen Pharmacogenetics and genomics 24 (9), 451-458, 2014 | 6 | 2014 |
| Abstract P2-16-21: A randomized phase I trial of nanoparticle albumin bound paclitaxel (nab-paclitaxel, Abraxane®) with or without mifepristone for advanced breast cancer R Nanda, P Chennamaneni, J Gibson, K Koetter, B Libao, M Skor, ... Cancer Research 73 (24_Supplement), P2-16-21-P2-16-21, 2013 | 6 | 2013 |
| A randomized phase I trial of nanoparticle albumin bound paclitaxel (nab-paclitaxel, Abraxane (R)) with or without mifepristone for advanced breast cancer R Nanda, P Chennamaneni, J Gibson, K Koetter, B Libao, M Skor, ... CANCER RESEARCH 73, 2013 | 5 | 2013 |
| Preclinical assessment of in vivo gene editing efficiency, specificity, and tolerability of EDIT-101, an investigational CRISPR treatment for Leber congenital amaurosis 10 (LCA10) M Stefanidakis, M Maeder, G Bounoutas, C Yudkoff, S Haskett, H Chao, ... Human Gene Therapy; Editas Medicine, Inc.: Cambridge, MA, USA, 2018 | 3 | 2018 |
| Self-inactivating Cas9: a method for reducing exposure while maintaining efficacy in virally-delivered Cas9 applications P Singhal, A Sadowski, R Baral, M Ahmed, M Skor, GS Bounoutas, ... EDITAS MEDICINE: PUBLICATIONS & PRESENTATIONS 24, 1, 2017 | 2 | 2017 |
| Abstract PD3-02: Second-generation selective glucocorticoid receptor modulators in triple-negative breast cancer DC West, DJ Hosfield, CG Mayne, MN Skor, SC Styke, CF Pierce, ... Cancer Research 76 (4_Supplement), PD3-02-PD3-02, 2016 | 2 | 2016 |
| Efficient In Vivo Gene Editing of Inherited Retinal Disease Genes in Mice and Non-Human Primates S Boye, M Stefanidakis, R Mepani, MN Skor, SW Gloskowski, J Horng, ... MOLECULAR THERAPY 25 (5), 353-354, 2017 | 1 | 2017 |
